Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    12853587 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
Conditions: Neoplasms;   Venous Thromboembolism
Intervention:
2 Active, not recruiting Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
3 Completed Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
4 Terminated Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
Conditions: Venous Thromboembolism;   Neoplasms
Interventions: Drug: low molecular weight heparin;   Drug: vitamin K antagonists
5 Completed Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT
Conditions: Gastric Cancer;   Gastroesophageal Cancer
Interventions: Drug: Enoxaparin;   Drug: Standard Chemotherapy

Indicates status has not been verified in more than two years